Literature DB >> 17435655

Extraintestinal manifestations of inflammatory bowel disease: focus on the musculoskeletal, dermatologic, and ocular manifestations.

Paul E Evans1, Darrell S Pardi.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17435655      PMCID： PMC1925026     

Source DB:  PubMed          Journal:  MedGenMed        ISSN： 1531-0132


× No keyword cloud information.
  30 in total

Review 1.  Exacerbation of inflammatory bowel disease by nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors: fact or fiction?

Authors:  Mario Guslandi
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

2.  Adalimumab reduces spinal symptoms in active ankylosing spondylitis: clinical and magnetic resonance imaging results of a fifty-two-week open-label trial.

Authors:  Hildrun Haibel; Martin Rudwaleit; Henning C Brandt; Zarho Grozdanovic; Joachim Listing; Hartmut Kupper; Jürgen Braun; Joachim Sieper
Journal:  Arthritis Rheum       Date:  2006-02

Review 3.  Extraintestinal manifestations and complications in inflammatory bowel diseases.

Authors:  Katja S Rothfuss; Eduard F Stange; Klaus R Herrlinger
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

4.  Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history.

Authors:  T R Orchard; B P Wordsworth; D P Jewell
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

Review 5.  Important cutaneous manifestations of inflammatory bowel disease.

Authors:  L B Trost; J K McDonnell
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

Review 6.  Management of extraintestinal manifestations and other complications of inflammatory bowel disease.

Authors:  Edward V Loftus
Journal:  Curr Gastroenterol Rep       Date:  2004-12

7.  The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study.

Authors:  C N Bernstein; J F Blanchard; W Leslie; A Wajda; B N Yu
Journal:  Ann Intern Med       Date:  2000-11-21       Impact factor: 25.391

8.  Computed tomography evaluation of the sacroiliac joints in Crohn disease. Radiologic/clinical correlation.

Authors:  W W Scott; E K Fishman; J E Kuhlman; C I Caskey; J J O'Brien; G S Walia; T M Bayless
Journal:  Skeletal Radiol       Date:  1990       Impact factor: 2.199

9.  Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients.

Authors:  F T Veloso; J Carvalho; F Magro
Journal:  J Clin Gastroenterol       Date:  1996-07       Impact factor: 3.062

10.  Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study.

Authors:  M Dougados; S vam der Linden; M Leirisalo-Repo; B Huitfeldt; R Juhlin; E Veys; H Zeidler; T K Kvien; I Olivieri; B Dijkmans
Journal:  Arthritis Rheum       Date:  1995-05
View more
  16 in total

1.  Review.

Authors:  Kofi Clarke; Jason M Swoger
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-07

2.  Isolated gastrocnemius myositis related to Crohn's disease.

Authors:  Zainab Mogul; Seymour Katz; Teresa R Bachman; Carlos Urmacher
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-07

Review 3.  Extraintestinal manifestations and complications in IBD.

Authors:  Claudia Ott; Jürgen Schölmerich
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-09       Impact factor: 46.802

Review 4.  Biological therapy for dermatological manifestations of inflammatory bowel disease.

Authors:  Maddalena Zippi; Roberta Pica; Daniela De Nitto; Paolo Paoluzi
Journal:  World J Clin Cases       Date:  2013-05-16       Impact factor: 1.337

5.  Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients.

Authors:  Maddalena Zippi; Claudia Corrado; Roberta Pica; Eleonora Veronica Avallone; Claudio Cassieri; Daniela De Nitto; Paolo Paoluzi; Piero Vernia
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

6.  Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients.

Authors:  Adam Weizman; Brian Huang; Dror Berel; Stephan R Targan; Marla Dubinsky; Phillip Fleshner; Andrew Ippoliti; Manreet Kaur; Deepa Panikkath; Steve Brant; Ioannis Oikonomou; Rick Duerr; John Rioux; Mark Silverberg; Jerome I Rotter; Eric Vasiliauskas; Talin Haritunians; David Shih; Dalin Li; Gil Y Melmed; Dermot P B McGovern
Journal:  Inflamm Bowel Dis       Date:  2014-03       Impact factor: 5.325

7.  Prevalence and characteristics of ophthalmological extra-intestinal manifestations in Chinese patients with inflammatory bowel disease.

Authors:  Ying-Chao Li; Wei-Zhi Li; Chang-Rui Wu; Yun Feng; Li Ren; Chen Mi; Yang Li
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

Review 8.  Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis.

Authors:  Maurizio Bellavia; Giovanni Tomasello; Marcello Romeo; Provvidenza Damiani; Attilio I Lo Monte; Luciano Lozio; Claudia Campanella; Antonella Marino Gammazza; Francesca Rappa; Giovanni Zummo; Massimo Cocchi; Everly Conway de Macario; Alberto J L Macario; Francesco Cappello
Journal:  Med Microbiol Immunol       Date:  2013-07-18       Impact factor: 3.402

9.  Skin manifestations of inflammatory bowel disease.

Authors:  Brian L Huang; Stephanie Chandra; David Quan Shih
Journal:  Front Physiol       Date:  2012-02-06       Impact factor: 4.566

Review 10.  Ophthalmic manifestations in patients with inflammatory bowel disease: A review.

Authors:  Leandro Lopes Troncoso; Ana Luiza Biancardi; Haroldo Vieira de Moraes; Cyrla Zaltman
Journal:  World J Gastroenterol       Date:  2017-08-28       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.